Partnership with China CDC on Infectious Disease Prevention and Control in China and Globally | CDC RFA GH18 1855

Opportunity Information: Apply for CDC RFA GH18 1855

The grant opportunity titled "Partnership with China CDC on Infectious Disease Prevention and Control in China and Globally" (Funding Opportunity Number: CDC RFA GH18 1855) is a discretionary, five-year cooperative agreement run by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically CDCs Center for Global Health (CGH). The core aim is to sustain and deepen collaboration between the United States and the government of China to reduce the risk of infectious disease transmission within China and internationally. The rationale is straightforward: outbreaks that begin or expand in one country can quickly become regional or global threats, so strengthening prevention and response capacity in a major global hub like China supports the health security of both countries and contributes to broader pandemic preparedness, while also reinforcing a bilateral public health relationship.

The program is organized around three broad goals. First, it seeks to conduct joint public health work to prevent, detect, and respond to emerging and re-emerging infectious diseases, as well as other public health emergencies in China that could have global consequences. This includes practical, operational collaboration in areas such as outbreak investigation, surveillance, and monitoring, where real-time coordination and shared technical approaches can improve speed and effectiveness of response. Second, the program emphasizes building Chinas own capacity to carry out these functions independently and at high quality over time. Capacity building here is meant in a broad public health sense, such as improving systems, workforce skills, emergency response structures, and the technical tools needed to identify and manage outbreaks early. Third, the opportunity is designed to strengthen Chinas role as an international public health partner, with an explicit focus on enabling China to support health security and public health system strengthening in other countries, not just within its own borders.

The activities described in the opportunity reflect a mix of fieldwork, technical assistance, systems strengthening, and international coordination. The collaboration may include joint investigations and monitoring of disease outbreaks, which can involve shared epidemiologic analysis, laboratory collaboration, and coordinated situational assessments. It also mentions piloting innovative public health interventions, suggesting that the partnership is expected to test new approaches in prevention or response and evaluate what works in real settings. Another named area is consultation on outbreak response and risk communication, which points to supporting clear, credible public messaging and community engagement during emergencies, alongside the technical response. The opportunity also highlights strengthening technical partnerships and broader public health capacity, indicating a focus on institutional and professional linkages that allow routine collaboration, shared training, and ongoing coordination beyond a single event.

A notable emphasis is placed on promoting rapid and transparent dissemination of public health data in China, reflecting the importance of timely, accurate information sharing for domestic containment and for global situational awareness. The opportunity also specifically references supporting the development of China CDCs Center for Global Public Health, which aligns with the third goal of helping China play a larger role internationally. In addition, it calls out joint support to the Africa CDC and collaboration on global public health activities in other countries, signaling that this is not only a bilateral China-U.S. effort but also a platform for coordinated engagement in broader global health security initiatives.

From an administrative standpoint, this funding mechanism is a cooperative agreement, meaning CDC expects to have substantial involvement in the work, such as providing technical direction, collaborating on planning, and coordinating activities with key partners. The listing indicates an expected single award, underscoring that this is designed as a focused, centrally coordinated partnership rather than a broad competitive program with many grantees. The eligible applicants field is listed as "Others" with further clarification referenced in the full announcement, implying that eligibility may be limited to specific types of institutions or organizations capable of carrying out an international public health partnership of this scale and sensitivity.

The opportunity was created on June 20, 2018, with an original application closing date of August 20, 2018, and applications were required to be submitted electronically by 11:59 p.m. Eastern Time on the due date. The assistance listing references CFDA number 93.318, placing it within CDCs global health portfolio. The notice also notes that the specific infectious disease threats addressed are expected to change over the project period depending on funding availability and evolving priorities, which is consistent with the reality of emerging threats and shifting outbreak landscapes. Overall, the grant is structured to support sustained, flexible, and operationally grounded collaboration that improves outbreak readiness and response in China, strengthens long-term public health capacity, and supports Chinas engagement as a contributor to global public health efforts.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Partnership with China CDC on Infectious Disease Prevention and Control in China and Globally" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
• This funding opportunity was created on Jun 20, 2018.
• Applicants must submit their applications by Aug 20, 2018 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH18 1855

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: